Successful medication withdrawal after cognitive-behavioral therapy in a treatment-resistant preadolescent male with obsessive-compulsive disorder

Depression and Anxiety

Volumn 26, Issue 1, 2009, Pages

  Goldstein, Robert B ^a   Storch, Eric A ^b   Lehmkuhl, Heather ^c   Geffken, Gary R ^d   Goodman, Wayne K ^e   Murphy, Tanya K ^b  

^a Private Practice   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Children; Cognitive behavioral; Medication withdrawal; Obsessive compulsive disorder

Indexed keywords

AMPHETAMINE; ATOMOXETINE; FLUOXETINE; NEUROLEPTIC AGENT; OXCARBAZEPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; COGNITIVE THERAPY; DRUG WITHDRAWAL; HUMAN; MALE; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; SCHOOL CHILD;

ADRENERGIC UPTAKE INHIBITORS; ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; PROPYLAMINES; RISPERIDONE; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 58549096729     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20448     Document Type: Article

References (9)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th ed.). Text revision (DSM-IV-TR). Washington, DC: American Psychiatric Press; 2000.
2. Abramowitz J, Whiteside SP, Deacon BJ. The effectiveness of treatment for pediatric obsessive-compulsive disorder: a metaanalysis. Behav Ther 2005;36:55-63.
3. Pediatric OCD Treatment Study (POTS) Team. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 2004;292:1969-1976.
4. Blanco C, Olfson M, Stein DJ, Simpson HB, Gameroff MJ, Narrow WH. Treatment of obsessive-compulsive disorder by US psychiatrists. J Clin Psychiatry 2006;67:946-951.
5. Kampman M, Keijsers GP, Hoogduin CA, Verbraak MJ. Addition of cognitive behaviour therapy for obsessive-compulsive disorder patients non-responding to fluoxetine. Acta Psychiatr Scand 2002;106:314-319.
6. Tolin DF, Maltby N, Diefenbach GJ, Hannan SE, Worhunsky P. Cognitive behavioral therapy for medication nonresponders with obsessive-compulsive disorder: a wait-list-controlled open trial. J Clin Psychiatry 2004;65:922-931.
7. Sallinen BJ, Nangle DW, O'Grady AC. Case study: successful medication withdrawal using cognitive-behavioral therapy for a preadolescent with OCD. J Am Acad Child Adolesc Psychiatry 2004;43:1441-1444.
8. Haupt DW Differential metabolic effects of antipsychotic treatments. Eur Neuropsychopharmacol. 2006;16(Suppl 3): S149-S155.
9. Storch EA, Geffken GR, Merlo LJ, et al. Cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: comparison of intensive and weekly approaches. J Am Acad Child Adolesc Psychiatry 2007;46:469-478.